These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 19183901)

  • 1. A case study for plant-made pharmaceuticals comparing different plant expression and production systems.
    Vancanneyt G; Dubald M; Schröder W; Peters J; Botterman J
    Methods Mol Biol; 2009; 483():209-21. PubMed ID: 19183901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sowing the seeds of success: pharmaceutical proteins from plants.
    Stoger E; Ma JK; Fischer R; Christou P
    Curr Opin Biotechnol; 2005 Apr; 16(2):167-73. PubMed ID: 15831382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production of recombinant proteins in suspension-cultured plant cells.
    Plasson C; Michel R; Lienard D; Saint-Jore-Dupas C; Sourrouille C; de March GG; Gomord V
    Methods Mol Biol; 2009; 483():145-61. PubMed ID: 19183898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant protein expression in Nicotiana.
    Matoba N; Davis KR; Palmer KE
    Methods Mol Biol; 2011; 701():199-219. PubMed ID: 21181532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plant-made pharmaceuticals: leading products and production platforms.
    Paul M; Ma JK
    Biotechnol Appl Biochem; 2011; 58(1):58-67. PubMed ID: 21446960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production and localization of recombinant pharmaceuticals in transgenic seeds.
    Rademacher T; Arcalis E; Stoger E
    Methods Mol Biol; 2009; 483():69-87. PubMed ID: 19183894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The production of recombinant pharmaceutical proteins in plants.
    Ma JK; Drake PM; Christou P
    Nat Rev Genet; 2003 Oct; 4(10):794-805. PubMed ID: 14526375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulatory issues for plant-made pharmaceuticals and vaccines.
    Streatfield SJ
    Expert Rev Vaccines; 2005 Aug; 4(4):591-601. PubMed ID: 16117714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production of plantibodies in Nicotiana plants.
    Ayala M; Gavilondo J; Rodríguez M; Fuentes A; Enríquez G; Pérez L; Cremata J; Pujol M
    Methods Mol Biol; 2009; 483():103-34. PubMed ID: 19183896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transgenic chloroplasts are efficient sites for high-yield production of the vaccinia virus envelope protein A27L in plant cellsdagger.
    Rigano MM; Manna C; Giulini A; Pedrazzini E; Capobianchi M; Castilletti C; Di Caro A; Ippolito G; Beggio P; De Giuli Morghen C; Monti L; Vitale A; Cardi T
    Plant Biotechnol J; 2009 Aug; 7(6):577-91. PubMed ID: 19508274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioreactor strategies for improving production yield and functionality of a recombinant human protein in transgenic tobacco cell cultures.
    Huang TK; Plesha MA; Falk BW; Dandekar AM; McDonald KA
    Biotechnol Bioeng; 2009 Feb; 102(2):508-20. PubMed ID: 18767186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plant-based production of biopharmaceuticals.
    Fischer R; Stoger E; Schillberg S; Christou P; Twyman RM
    Curr Opin Plant Biol; 2004 Apr; 7(2):152-8. PubMed ID: 15003215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plant-derived vaccines and other therapeutics produced in contained systems.
    Franconi R; Demurtas OC; Massa S
    Expert Rev Vaccines; 2010 Aug; 9(8):877-92. PubMed ID: 20673011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The moss bioreactor.
    Decker EL; Reski R
    Curr Opin Plant Biol; 2004 Apr; 7(2):166-70. PubMed ID: 15003217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Approaches to achieve high-level heterologous protein production in plants.
    Streatfield SJ
    Plant Biotechnol J; 2007 Jan; 5(1):2-15. PubMed ID: 17207252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality assessment of recombinant proteins produced in plants.
    Medrano G; Dolan MC; Condori J; Radin DN; Cramer CL
    Methods Mol Biol; 2012; 824():535-64. PubMed ID: 22160919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. From Neanderthal to nanobiotech: from plant potions to pharming with plant factories.
    Sourrouille C; Marshall B; Liénard D; Faye L
    Methods Mol Biol; 2009; 483():1-23. PubMed ID: 19183890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Translocation of aprotinin, a therapeutic protease inhibitor, into the thylakoid lumen of genetically engineered tobacco chloroplasts.
    Tissot G; Canard H; Nadai M; Martone A; Botterman J; Dubald M
    Plant Biotechnol J; 2008 Apr; 6(3):309-20. PubMed ID: 18266824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transient co-expression for fast and high-yield production of antibodies with human-like N-glycans in plants.
    Vézina LP; Faye L; Lerouge P; D'Aoust MA; Marquet-Blouin E; Burel C; Lavoie PO; Bardor M; Gomord V
    Plant Biotechnol J; 2009 Jun; 7(5):442-55. PubMed ID: 19422604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Foreign protein degradation and instability in plants and plant tissue cultures.
    Doran PM
    Trends Biotechnol; 2006 Sep; 24(9):426-32. PubMed ID: 16843560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.